A groupH team has worked with the AMR Global R&D Hub over the last 12 months to produce data and analysis for a report on epidemiology and revenue projections for two therapeutics and two diagnostics in the Gram-negative space.

Click on the image below to read the full report, delivering commercial insights into novel treatments and diagnostics to combat antimicrobial resistance